Fox Run Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-3,456
Closed -$911K – 1137
2026
Q1
$911K Sell
3,456
-3,630
-51% -$983K 0.16% 212
2025
Q4
$1.78M Buy
+7,086
New +$1.88M 0.27% 46
2024
Q4
– Sell
-4,203
Closed -$939K – 1036
2024
Q3
$939K Buy
+4,203
New +$924K 0.21% 150
2023
Q1
– Sell
-2,315
Closed -$468K – 811
2022
Q4
$468K Buy
2,315
+738
+47% +$144K 0.19% 200
2022
Q3
$278K Buy
+1,577
New +$323K 0.11% 374
2022
Q1
– Sell
-1,177
Closed -$318K – 621
2021
Q4
$318K Sell
1,177
-181
-13% -$44.8K 0.19% 210
2021
Q3
$328K Buy
+1,358
New +$342K 0.21% 196
2019
Q2
– Sell
-4,446
Closed -$584K – 532
2019
Q1
$584K Buy
4,446
+2,040
+85% +$251K 0.33% 74
2018
Q4
$261K Buy
+2,406
New +$322K 0.14% 310
2017
Q1
– Sell
-4,307
Closed -$475K – 675
2016
Q4
$475K Buy
4,307
+1,281
+42% +$142K 0.25% 137
2016
Q3
$357K Sell
3,026
-4,307
-59% -$508K 0.21% 197
2016
Q2
$821K Buy
7,333
+4,423
+152% +$476K 0.4% 24
2016
Q1
$293K Buy
2,910
+233
+9% +$22.3K 0.2% 230
2015
Q4
$284K Buy
+2,677
New +$276K 0.22% 184

Other funds holding LH

Fox Run Management's LH Position: Q2 2026 in Review

Fox Run Management sold out of Labcorp (LH) in Q2 2026, closing a stake of 3,456 shares — an estimated $911K sold.

Fox Run Management first reported a position in LH in Q4 2015 and held it in 14 quarters. The position peaked at $1.78M in Q4 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Fox Run Management reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 3,456 Labcorp shares in Q2 2026, an estimated $911K.
  • Fox Run Management first reported a position in Labcorp in Q4 2015 and held it in 14 quarters.
  • Fox Run Management's Labcorp position peaked at $1.78M in Q4 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.